Greenbrook TMS to Participate at 31st Annual Piper Jaffray Healthcare Conference
Greenbrook TMS Inc. (TSX: GTMS) ("Greenbrook" or the "Company"), the market leader in Transcranial Magnetic Stimulation ("TMS") in the United States, is pleased to announce that Bill Leonard, Chief Executive Officer, will present at the 31st Annual Piper Jaffray Healthcare Conference in New York, NY on December 5, 2019 at 11:30 a.m. Eastern Time.
About Greenbrook TMS Inc.
Operating through 112 Company-operated treatment centers, Greenbrook is a leading provider of TMS, an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided more than 320,000 TMS treatments to over 9,000 patients struggling with depression.
News published on and distributed by:
